The biobetters market, an emerging segment within the biotechnology industry, represents an exciting frontier in the development of next-generation biologic therapies. These therapeutics, designed as improved versions of existing biologic drugs, offer enhanced efficacy, reduced side effects, and longer-lasting results. Biobetters are distinct from biosimilars, as they involve the...